This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohner, P.
Right arrow Articles by Pfyffer, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohner, P.
Right arrow Articles by Pfyffer, G. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 1998, p. 3046-3047, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Rapid Diagnosis of Pulmonary Tuberculosis with the LCx Mycobacterium tuberculosis Assay and Comparison with Conventional Diagnostic Techniques

Peter Rohner,1,* Esther I. M. Jahn,2 Beatrice Ninet,1 Concetta Ionati,1 Rainer Weber,3 Raymond Auckenthaler,1 and Gaby E. Pfyffer2

Infectious Disease Division, Bacteriology Laboratory, University Hospital Geneva, 1211 Geneva,1 Swiss National Center for Mycobacteria, Department of Medical Microbiology, University of Zurich, 8028 Zurich,2 and Division of Infectious Disease, Department of Internal Medicine, University Hospital, 8091 Zurich,3 Switzerland

Received 16 December 1997/Returned for modification 9 March 1998/Accepted 2 July 1998

The LCx MTB amplification assay is a nucleic acid amplification test intended for the direct detection of Mycobacterium tuberculosis complex in respiratory specimens. We evaluated its performance on 2,001 consecutive respiratory specimens; 78 were culture positive for M. tuberculosis. Sensitivity, specificity, and positive and negative predictive values of this assay for all specimens compared to culture results were 88.5, 97.7, 60.5, and 99.5%, respectively. When referred to resolved clinical diagnosis of active tuberculosis, these values improved to 90.2, 98.4, 72.8, and 99.5%, respectively.


* Corresponding author. Mailing address: Division des Maladies Infectieuses, Laboratoire Central de Bactériologie, Hôpital Cantonal de Genève, 24 Rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. Phone: 41 22 37 27 313. Fax: 41 22 37 27 304. E-mail: Peter.Rohner{at}hcuge.ch.


Journal of Clinical Microbiology, October 1998, p. 3046-3047, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Greco, S, Girardi, E, Navarra, A, Saltini, C (2006). Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 61: 783-790 [Abstract] [Full Text]  
  • Danes, C., Gonzalez-Martin, J., Pumarola, T., Rano, A., Benito, N., Torres, A., Moreno, A., Rovira, M., Puig de la Bellacasa, J. (2002). Pulmonary Infiltrates in Immunosuppressed Patients: Analysis of a Diagnostic Protocol. J. Clin. Microbiol. 40: 2134-2140 [Abstract] [Full Text]  
  • Lumb, R., Davies, K., Dawson, D., Gibb, R., Gottlieb, T., Kershaw, C., Kociuba, K., Nimmo, G., Sangster, N., Worthington, M., Bastian, I. (1999). Multicenter Evaluation of the Abbott LCx Mycobacterium tuberculosis Ligase Chain Reaction Assay. J. Clin. Microbiol. 37: 3102-3107 [Abstract] [Full Text]